Covid-19 update: South Africa reports 7,238 new cases and 31 deaths

National Institute of Infectious DiseasesNICD), a division of the National Health Laboratory Service, has reported 7,238 new cases of Covid-19 in the past 24 hours.

This brings the total number of laboratory-confirmed cases to 3,915,258. The increase represents 24.8% positive results.

Today, the majority of new cases are in Gauteng (34%), followed by the Western Cape (23%). KwaZulu-Natal accounted for 15%; The Eastern Cape was 10% and the Free State was 6%. Northern Cape was 5%; the Northwest accounted for 4%; Mpumalanga accounted for 3% and Limpopo 1% of today’s cases.

31 deaths were also registered, of which 12 occurred in the last 24-48 hours. This brings the total death toll to date to 100,898.

“Due to ongoing audits by the National Department of Health (NDoH), there may be a buildup of reported deaths from Covid-19,” the NICD said in a statement.

24,992,827 tests were carried out in both the public and private sectors.

Over the past 24 hours, the number of hospitalizations has increased by 136.

WHO approves Chinese vaccine CanSinoBIO against Covid-19

The World Health Organization on Thursday authorized the use of a single-dose Covid-19 vaccine from Chinese manufacturer CanSinoBIO, the ninth shot given the WHO green light.

The WHO has given the Tianjin company’s Convidecia vaccine an emergency use list (EUL) as China grapples with a resurgence of a virus caused by a variant of Omicron.

This is the third Chinese-made vaccine approved by the WHO after Sinovac and Sinopharm.

According to the WHO, Convidecia was 64% effective against symptomatic disease and 92% effective against severe Covid-19.

“The vaccine meets WHO standards for protection against Covid-19 and… the benefits of the vaccine far outweigh the risks,” the UN health agency said in a statement.

WHO vaccine experts recommended it for people aged 18 and over.

The jab has already been launched in China, Argentina, Chile, Malaysia, Mexico and Pakistan.

The WHO has now given EUL status to nine Covid-19 vaccines and their variations: Pfizer/BioNTech, AstraZeneca, Janssen, Moderna, Sinovac, Sinopharm, Bharat Biotech, Novavax, and now CanSinoBIO.

The UN health agency began reviewing current data on the CanSinoBIO vaccine in August.

The WHO says EUL approval gives countries, funds, purchasing agencies and communities the confidence that a vaccine meets international standards.

ALSO READ: SAHPRA: Benefits of J&J Vaccine in Preventing Covid-19 Far Outweigh Risks

Listing by WHO allows countries to quickly approve and import a vaccine for distribution, especially those that do not have their own regulatory body that meets international standards.

It also opens the door for vaccinations to the Covax Global Vaccine Exchange Center, which aims to ensure equal access to doses worldwide, especially in poorer countries.

China – the latest major global economy to adopt a strict zero-spread policy for Covid-19 – is battling an economic downturn due to prolonged virus lockdowns that have narrowed supply chains, stifled demand and halted production.

Additional AFP reporting